Using the Oncomine database, we first analyzed ANXA6 mRNA levels in tissue samples from 45 cervical cancer patients and found that it was significantly downregulated in tumor tissues (Figure 1C). This evidence concerns the gene ANXA6 and cervical carcinoma.